UK drug major GSK is considering a bid for a 51 per cent share of India’s Shantha Biotech after European rival Sanofi Aventis pulled out of an acquisition deal last week, according to India’s Economic Times.
http://www.in-pharmatechnologist.com/Industry-Drivers/GSK-may-move-for-51-of-Shantha

This entry was posted on Tuesday, June 16th, 2009 at 4:21 am and is filed under Business News. You can follow any responses to this entry through the RSS 2.0 feed. Responses are currently closed, but you can trackback from your own site.